Neogen (NEOG) Financials

Neogen logo
$10.88 -0.35 (-3.12%)
Closing price 04:00 PM Eastern
Extended Trading
$10.84 -0.04 (-0.37%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Neogen

Annual Income Statements for Neogen

This table shows Neogen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
Net Income / (Loss) Attributable to Common Shareholders
37 44 63 60 59 61 48 -23 -9.40 -1,092 -7.90
Consolidated Net Income / (Loss)
37 44 63 60 59 61 48 -23 -9.40 -1,092 -7.90
Net Income / (Loss) Continuing Operations
37 44 63 60 59 61 48 -23 -9.40 -1,092 -7.90
Total Pre-Tax Income
56 67 73 73 72 75 60 -22 -14 -1,133 -9.00
Total Operating Income
56 65 70 68 68 74 59 38 59 -1,061 -22
Total Gross Profit
153 169 186 192 196 215 243 406 464 421 409
Total Revenue
321 358 398 414 418 468 527 822 924 895 870
Operating Revenue
321 358 398 414 418 468 527 822 924 895 870
Total Cost of Revenue
168 189 212 222 222 253 284 416 460 473 462
Operating Cost of Revenue
168 189 212 222 222 253 284 416 460 473 462
Total Operating Expenses
97 104 116 124 129 141 184 368 405 1,482 430
Selling, General & Admin Expense
29 34 38 41 44 51 83 201 200 218 245
Marketing Expense
58 59 67 70 70 73 85 141 183 184 167
Research & Development Expense
9.89 10 11 13 15 16 17 26 23 21 18
Impairment Charge
- - - - - - - 0.00 0.00 1,059 0.00
Total Other Income / (Expense), net
-0.87 1.73 3.27 4.87 4.78 1.10 1.59 -60 -73 -72 13
Interest Expense
- - - - - 0.08 0.07 56 67 69 58
Interest & Investment Income
0.54 1.01 2.19 4.83 5.99 1.69 1.34 3.17 0.00 0.00 0.00
Other Income / (Expense), net
-1.41 0.72 1.08 0.03 -1.21 -0.52 0.32 -6.76 -5.90 -3.60 70
Income Tax Expense
19 23 10 13 13 14 12 0.83 -4.90 -41 -1.10
Basic Earnings per Share
$0.73 $0.87 $1.23 $0.58 $0.57 $0.57 $0.45 ($0.12) ($0.04) ($5.03) ($0.04)
Weighted Average Basic Shares Outstanding
37.40M 50.54M 51.36M 103.78M 105.10M 106.50M 107.68M 188.88M 216.50M 216.90M 217.50M
Diluted Earnings per Share
$0.72 $0.86 $1.21 $0.57 $0.56 $0.57 $0.45 ($0.12) ($0.04) ($5.03) ($0.04)
Weighted Average Diluted Shares Outstanding
37.40M 50.54M 52.15M 104.85M 105.72M 107.12M 108.02M 188.88M 216.50M 216.90M 217.50M
Weighted Average Basic & Diluted Shares Outstanding
37.40M 50.54M 51.36M 51.89M 52.96M 107.48M 107.84M 216.31M 216.69M 217.21M 218.06M

Quarterly Income Statements for Neogen

This table shows Neogen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-2.02 -5.42 -13 -456 -11 -612 36 -16 -17 -11 -12
Consolidated Net Income / (Loss)
-2.02 -5.42 -13 -456 -11 -612 36 -16 -17 -11 -12
Net Income / (Loss) Continuing Operations
-2.02 -5.42 -13 -456 -11 -612 36 -16 -17 -11 -12
Total Pre-Tax Income
-5.82 -6.40 -16 -477 -9.70 -631 44 -20 -20 -12 -15
Total Operating Income
12 13 2.26 -457 5.40 -611 -16 -5.38 -3.30 3.17 -1.80
Total Gross Profit
117 113 105 113 110 93 95 107 99 108 106
Total Revenue
229 237 217 231 221 225 209 225 211 225 223
Operating Revenue
229 237 217 231 221 225 209 225 211 225 223
Total Cost of Revenue
112 123 112 118 111 133 114 118 112 117 117
Operating Cost of Revenue
112 123 112 118 111 133 114 118 112 117 117
Total Operating Expenses
105 100 103 571 105 704 111 112 102 105 107
Selling, General & Admin Expense
52 51 52 58 56 53 61 65 60 59 59
Marketing Expense
48 44 46 47 45 47 45 42 38 41 42
Research & Development Expense
4.85 5.15 5.20 5.11 4.50 6.29 5.10 4.56 3.80 4.91 6.50
Impairment Charge
0.00 - - 461 0.00 - 0.00 0.00 0.00 - 0.00
Total Other Income / (Expense), net
-18 -19 -18 -19 -15 -20 60 -15 -17 -15 -13
Interest Expense
18 19 19 18 17 15 16 15 14 12 14
Other Income / (Expense), net
-1.17 -1.92 -0.24 -1.72 1.90 -3.54 75 -0.73 -3.10 -1.39 0.70
Income Tax Expense
-3.80 -0.98 -3.00 -20 1.20 -19 7.50 -4.44 -3.30 -0.83 -3.00
Basic Earnings per Share
($0.01) ($0.02) ($0.06) ($2.10) ($0.05) ($2.82) $0.17 ($0.07) ($0.08) ($0.06) ($0.05)
Weighted Average Basic Shares Outstanding
216.60M 216.48M 216.70M 216.81M 217.03M 216.90M 217.20M 217.41M 217.67M 217.50M 218.10M
Diluted Earnings per Share
($0.01) ($0.02) ($0.06) ($2.10) ($0.05) ($2.82) $0.17 ($0.07) ($0.08) ($0.06) ($0.05)
Weighted Average Diluted Shares Outstanding
216.60M 216.48M 216.70M 216.81M 217.03M 216.90M 217.30M 217.41M 217.67M 217.50M 218.10M
Weighted Average Basic & Diluted Shares Outstanding
216.61M 216.69M - 216.94M 217.04M 217.21M 217.30M 217.53M 217.67M 218.06M 218.31M

Annual Cash Flow Statements for Neogen

This table details how cash moves in and out of Neogen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
Net Change in Cash & Equivalents
-11 22 5.51 -41 25 9.33 -31 119 7.40 -42 57
Net Cash From Operating Activities
35 60 69 64 86 81 68 41 35 58 83
Net Cash From Continuing Operating Activities
35 60 69 64 86 81 68 41 35 58 83
Net Income / (Loss) Continuing Operations
37 44 63 60 59 61 48 -23 -9.40 -1,092 -7.90
Consolidated Net Income / (Loss)
37 44 63 60 59 61 48 -23 -9.40 -1,092 -7.90
Depreciation Expense
12 15 17 18 18 21 24 88 117 120 116
Amortization Expense
- - - - - 0.00 0.44 4.82 7.90 9.40 7.60
Non-Cash Adjustments To Reconcile Net Income
2.52 1.34 4.91 5.54 6.47 6.44 0.02 14 20 1,085 -61
Changes in Operating Assets and Liabilities, net
-16 0.27 -16 -20 1.54 -7.27 -4.42 -43 -100 -64 28
Net Cash From Investing Activities
-61 -62 -83 -119 -89 -106 -97 201 -29 -99 71
Net Cash From Continuing Investing Activities
-61 -62 -83 -119 -89 -106 -97 201 -29 -99 71
Purchase of Property, Plant & Equipment
-14 -15 -21 -15 -24 -27 -24 -66 -111 -105 -51
Sale of Property, Plant & Equipment
- - - - - 0.00 0.00 0.83 0.10 5.10 0.10
Divestitures
- - - - - - - - 0.00 0.00 122
Sale and/or Maturity of Investments
147 149 300 339 407 765 382 267 82 0.30 0.00
Net Cash From Financing Activities
15 25 23 14 29 34 6.81 -118 1.90 -1.60 -99
Net Cash From Continuing Financing Activities
15 25 23 14 29 34 6.81 -118 1.90 -1.60 -99
Repayment of Debt
- - - - - 0.00 0.00 -119 0.00 -552 -100
Issuance of Debt
- - - - - - - 0.00 0.00 550 0.00
Issuance of Common Equity
- 21 23 17 29 35 7.93 1.20 2.40 2.20 1.60
Other Financing Activities, net
15 3.92 -0.42 0.00 0.00 -1.09 -1.12 0.00 -0.50 -1.80 -1.00
Other Net Changes in Cash
- - - - - - - -5.22 -0.50 1.00 2.20
Cash Interest Paid
- - - - - 0.08 0.07 43 73 68 58
Cash Income Taxes Paid
13 18 15 13 7.36 15 17 15 22 27 18

Quarterly Cash Flow Statements for Neogen

This table details how cash moves in and out of Neogen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Net Change in Cash & Equivalents
-44 9.17 -50 20 -13 1.30 9.80 6.46 15 26 -14
Net Cash From Operating Activities
-30 27 -18 40 19 17 11 19 23 30 13
Net Cash From Continuing Operating Activities
-30 27 -18 40 19 17 11 19 23 30 13
Net Income / (Loss) Continuing Operations
-2.02 -5.42 -13 -456 -11 -612 36 -16 -17 -11 -12
Consolidated Net Income / (Loss)
-2.02 -5.42 -13 -456 -11 -612 36 -16 -17 -11 -12
Depreciation Expense
30 29 30 30 29 30 29 29 29 29 29
Amortization Expense
0.86 5.37 0.86 0.86 0.86 6.83 1.90 0.48 0.48 6.10 1.80
Non-Cash Adjustments To Reconcile Net Income
3.69 9.64 3.80 474 6.18 602 -71 4.56 1.56 4.00 4.20
Changes in Operating Assets and Liabilities, net
-62 -12 -40 -8.00 -6.09 -9.86 14 1.40 8.76 2.00 -10
Net Cash From Investing Activities
-15 -18 -34 -17 -32 -16 98 -12 -12 -4.00 -8.20
Net Cash From Continuing Investing Activities
-15 -18 -34 -17 -32 -16 98 -12 -12 -4.00 -8.20
Purchase of Property, Plant & Equipment
-32 -24 -38 -17 -33 -16 -24 -12 -12 -4.00 -8.20
Divestitures
- - 0.00 - - - 122 - -0.02 - 0.00
Net Cash From Financing Activities
1.25 -0.08 0.98 -1.41 0.95 -2.11 -99 -0.45 0.74 -0.30 -19
Net Cash From Continuing Financing Activities
1.25 -0.08 0.98 -1.41 0.95 -2.11 -99 -0.45 0.74 -0.30 -19
Repayment of Debt
-0.06 -0.09 -0.10 0.10 - - -100 - - - -20
Issuance of Common Equity
1.30 0.01 1.08 0.11 1.06 - 0.90 -0.03 0.82 -0.10 2.20
Other Financing Activities, net
- - 0.00 -1.61 -0.12 -0.09 -0.30 -0.42 -0.08 -0.20 -1.20
Effect of Exchange Rate Changes
- - 0.46 - -0.39 - 0.70 - - - 0.80
Cash Interest Paid
- - - - - - 23 - - - 22
Cash Income Taxes Paid
- - - - - - 5.00 - - - 2.80

Annual Balance Sheets for Neogen

This table presents Neogen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
Total Assets
450 528 618 696 797 920 993 4,554 4,549 3,444 3,346
Total Current Assets
248 293 376 450 537 591 627 586 589 577 605
Cash & Equivalents
55 78 83 42 66 76 44 163 171 129 186
Accounts Receivable
68 69 79 83 85 92 100 153 173 153 147
Inventories, net
64 73 76 86 95 101 122 134 189 191 144
Prepaid Expenses
8.41 7.61 9.89 13 14 18 24 53 56 53 60
Other Current Nonoperating Assets
- - - - - - - - 0.00 50 68
Plant, Property, & Equipment, net
55 62 73 75 79 100 111 199 277 339 330
Total Noncurrent Assets
147 174 169 171 181 228 256 3,770 3,682 2,528 2,412
Goodwill
89 105 100 104 110 131 143 2,137 2,136 1,065 1,047
Intangible Assets
59 69 15 16 67 92 108 1,605 1,512 1,411 1,318
Other Noncurrent Operating Assets
- - 55 52 4.18 4.50 5.34 27 35 52 46
Total Liabilities & Shareholders' Equity
450 528 618 696 797 920 993 4,554 4,549 3,444 3,346
Total Liabilities
46 57 58 58 72 80 106 1,420 1,405 1,373 1,253
Total Current Liabilities
29 36 39 38 48 54 78 145 154 174 158
Short-Term Debt
- - - - - - - - 2.45 19 0.00
Accounts Payable
16 16 21 19 26 24 35 77 83 80 79
Current Deferred Revenue
- - - - - 3.40 5.46 4.62 4.63 5.60 3.60
Current Deferred & Payable Income Tax Liabilities
0.00 0.94 0.17 0.60 1.46 1.85 2.13 6.95 10 5.60 7.20
Current Employee Benefit Liabilities
4.99 5.00 6.07 7.09 7.74 11 11 25 20 14 27
Other Current Liabilities
- - - - - - - 21 23 32 24
Other Current Nonoperating Liabilities
- - - - - - 0.00 11 11 18 18
Total Noncurrent Liabilities
17 21 19 20 24 26 28 1,275 1,250 1,199 1,095
Long-Term Debt
- - - - - - 0.00 885 888 875 794
Noncurrent Deferred & Payable Income Tax Liabilities
15 17 14 16 18 22 17 353 327 281 258
Other Noncurrent Operating Liabilities
2.42 3.60 5.04 3.97 5.39 4.30 11 36 35 43 44
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
404 472 560 638 725 840 887 3,134 3,144 2,071 2,093
Total Preferred & Common Equity
404 472 560 638 725 840 887 3,134 3,144 2,071 2,093
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
404 472 560 638 725 840 887 3,134 3,144 2,071 2,093
Common Stock
156 183 211 230 266 312 327 2,602 2,619 2,637 2,651
Retained Earnings
252 296 359 419 479 540 588 565 556 -536 -544
Accumulated Other Comprehensive Income / (Loss)
-3.95 -7.20 -9.75 -12 -20 -11 -28 -33 -30 -29 -14

Quarterly Balance Sheets for Neogen

This table presents Neogen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 2/28/2023 8/31/2024 11/30/2023 2/29/2024 8/31/2024 11/30/2024 2/28/2025 8/31/2025 11/30/2025 2/28/2026 8/31/2026
Total Assets
4,509 4,503 4,602 4,582 4,503 4,054 4,036 3,378 3,360 3,359 3,303
Total Current Assets
555 541 624 602 541 570 552 524 575 590 583
Cash & Equivalents
67 120 206 161 120 140 128 139 145 160 172
Accounts Receivable
146 168 150 174 168 164 160 138 132 137 136
Inventories, net
144 199 161 182 199 198 205 193 163 162 146
Prepaid Expenses
82 54 83 78 54 68 58 53 58 63 58
Other Current Nonoperating Assets
- - - - - - - 0.00 77 68 70
Plant, Property, & Equipment, net
165 301 244 272 301 311 328 346 332 332 330
Total Noncurrent Assets
3,789 3,662 3,734 3,708 3,662 3,173 3,157 2,508 2,453 2,437 2,391
Goodwill
2,135 2,137 2,138 2,136 2,137 1,673 1,672 1,066 1,046 1,048 1,048
Intangible Assets
1,634 1,490 1,565 1,540 1,490 1,463 1,439 1,389 1,359 1,342 1,296
Other Noncurrent Operating Assets
19 34 31 32 34 37 46 53 48 48 48
Total Liabilities & Shareholders' Equity
4,509 4,503 4,602 4,582 4,503 4,054 4,036 3,378 3,360 3,359 3,303
Total Liabilities
1,383 1,368 1,455 1,436 1,368 1,385 1,376 1,260 1,255 1,257 1,217
Total Current Liabilities
107 123 177 158 123 151 141 146 147 151 150
Short-Term Debt
- - 2.57 - 2.65 2.58 - 0.00 0.00 0.00 0.00
Accounts Payable
60 61 112 90 61 80 72 77 63 75 78
Current Deferred Revenue
6.77 5.64 4.68 5.49 5.64 5.65 5.77 5.82 3.87 3.90 3.60
Current Deferred & Payable Income Tax Liabilities
1.65 11 10 12 11 11 13 9.45 8.96 9.90 8.70
Current Employee Benefit Liabilities
17 16 16 20 16 16 18 20 20 24 22
Other Current Liabilities
- 25 - 2.52 22 25 28 31 31 28 27
Other Current Nonoperating Liabilities
3.44 3.55 11 3.44 3.55 11 3.44 3.56 20 9.90 11
Total Noncurrent Liabilities
1,276 1,245 1,278 1,278 1,245 1,234 1,235 1,113 1,108 1,106 1,067
Long-Term Debt
885 889 887 888 889 890 891 793 793 793 774
Noncurrent Deferred & Payable Income Tax Liabilities
363 318 355 354 318 302 301 277 274 269 251
Other Noncurrent Operating Liabilities
29 39 36 37 39 42 43 44 42 44 42
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,126 3,135 3,148 3,146 3,135 2,669 2,660 2,119 2,104 2,102 2,086
Total Preferred & Common Equity
3,126 3,135 3,148 3,146 3,135 2,669 2,660 2,119 2,104 2,102 2,086
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,126 3,135 3,148 3,146 3,135 2,669 2,660 2,119 2,104 2,102 2,086
Common Stock
2,599 2,624 2,610 2,615 2,624 2,627 2,632 2,642 2,646 2,648 2,655
Retained Earnings
559 543 563 561 543 87 76 -500 -516 -533 -556
Accumulated Other Comprehensive Income / (Loss)
-33 -31 -25 -29 -31 -45 -48 -23 -26 -13 -12

Annual Metrics And Ratios for Neogen

This table displays calculated financial ratios and metrics derived from Neogen's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
DEI Shares Outstanding
- - - - - - - - - - 217,673,041.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 217,673,041.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -0.04
Growth Metrics
- - - - - - - - - - -
Revenue Growth
13.50% 11.52% 11.07% 4.09% 0.96% 12.03% 12.53% 56.02% 12.37% -3.20% -2.72%
EBITDA Growth
7.71% 19.66% 9.93% -2.92% -1.21% 11.79% -12.27% 49.20% 43.12% -627.47% 118.44%
EBIT Growth
6.34% 19.45% 8.55% -4.42% -2.66% 11.07% -19.98% -47.82% 71.45% -2,119.08% 104.57%
NOPAT Growth
8.36% 15.41% 41.01% -7.01% -1.11% 8.01% -21.60% -44.16% 56.37% -1,908.63% 97.96%
Net Income Growth
8.82% 20.35% 43.76% -4.81% -1.16% 2.37% -20.65% -147.34% 58.81% -11,491.59% 99.28%
EPS Growth
8.82% 20.35% 40.70% -4.81% -1.16% 2.37% -21.05% -126.67% 66.67% -12,475.00% 99.20%
Operating Cash Flow Growth
-19.32% 70.60% 14.69% -7.65% 34.52% -5.58% -16.09% -39.70% -14.05% 65.17% 42.96%
Free Cash Flow Firm Growth
-175.34% 154.29% 253.52% -9.87% 25.45% -140.19% 99.99% -349,034,399.41% 98.58% 774.63% -58.09%
Invested Capital Growth
24.08% 10.72% 6.47% 5.97% 3.04% 20.39% 10.24% 647.59% 2.31% -27.65% -5.45%
Revenue Q/Q Growth
3.70% 1.54% 3.27% 0.40% -0.16% 4.08% 2.46% 14.11% -0.54% 0.00% -0.01%
EBITDA Q/Q Growth
2.15% 5.69% 0.89% -0.98% 2.26% 1.74% -1.60% 33.81% -5.66% 0.00% 138.99%
EBIT Q/Q Growth
1.58% 5.94% 0.57% -1.55% 2.49% 0.73% -2.84% 25.35% -20.36% 0.00% 108.56%
NOPAT Q/Q Growth
1.16% 6.08% 8.61% -3.86% 0.36% 0.82% -3.29% 16.81% -15.04% 0.00% 96.60%
Net Income Q/Q Growth
1.07% 6.47% 8.69% -2.79% 0.90% -0.96% -1.63% -69.62% -701.60% 0.00% 98.70%
EPS Q/Q Growth
1.07% 6.47% 7.08% -2.79% 0.90% -0.96% -2.17% -100.00% -500.00% 0.00% 98.57%
Operating Cash Flow Q/Q Growth
-16.78% 14.79% 12.11% -2.56% 5.86% -4.32% -2.27% 238.85% -64.55% -14.91% 19.81%
Free Cash Flow Firm Q/Q Growth
-339.24% 144.13% 8.37% 0.94% -0.79% -63.45% -100.02% 1.76% -563.02% 0.00% -54.68%
Invested Capital Q/Q Growth
11.91% -0.66% -0.12% -0.80% -0.64% 1.09% 1.85% -1.18% 0.10% 0.00% -1.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.64% 47.15% 46.81% 46.34% 46.94% 45.91% 46.10% 49.36% 50.19% 47.10% 46.93%
EBITDA Margin
20.90% 22.43% 22.20% 20.70% 20.26% 20.21% 15.76% 15.07% 19.19% -104.59% 19.82%
Operating Margin
17.55% 18.13% 17.64% 16.44% 16.15% 15.83% 11.12% 4.56% 6.35% -118.59% -2.48%
EBIT Margin
17.11% 18.33% 17.91% 16.45% 15.86% 15.72% 11.18% 3.74% 5.71% -118.99% 5.58%
Profit (Net Income) Margin
11.37% 12.27% 15.89% 14.53% 14.22% 13.00% 9.16% -2.78% -1.02% -122.06% -0.91%
Tax Burden Percent
65.82% 65.95% 86.05% 82.48% 82.26% 80.89% 80.23% 103.76% 65.86% 96.38% 87.78%
Interest Burden Percent
100.98% 101.54% 103.07% 107.09% 109.04% 102.19% 102.15% -71.67% -27.13% 106.44% -18.52%
Effective Tax Rate
34.18% 34.05% 13.95% 17.52% 17.74% 19.11% 19.77% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
13.87% 13.72% 17.83% 15.61% 14.78% 14.27% 9.74% 1.22% 1.07% -22.24% -0.55%
ROIC Less NNEP Spread (ROIC-NNEP)
14.39% 12.81% 16.24% 13.93% 13.49% 14.03% 9.41% -35.17% -6.25% -69.99% 0.56%
Return on Net Nonoperating Assets (RNNOA)
-4.19% -3.68% -5.58% -5.56% -6.05% -6.49% -4.15% -2.36% -1.37% -19.64% 0.18%
Return on Equity (ROE)
9.68% 10.04% 12.25% 10.05% 8.73% 7.78% 5.59% -1.14% -0.30% -41.88% -0.38%
Cash Return on Invested Capital (CROIC)
-7.62% 3.55% 11.56% 9.81% 11.78% -4.23% 0.00% -151.58% -1.21% 9.84% 5.05%
Operating Return on Assets (OROA)
13.06% 13.42% 12.43% 10.37% 8.88% 8.58% 6.16% 1.11% 1.16% -26.64% 1.43%
Return on Assets (ROA)
8.68% 8.99% 11.03% 9.16% 7.97% 7.09% 5.05% -0.82% -0.21% -27.33% -0.23%
Return on Common Equity (ROCE)
9.68% 10.04% 12.25% 10.05% 8.73% 7.78% 5.59% -1.14% -0.30% -41.88% -0.38%
Return on Equity Simple (ROE_SIMPLE)
9.04% 9.32% 11.28% 9.43% 8.20% 7.24% 5.44% -0.73% -0.30% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
37 43 60 56 56 60 47 26 41 -743 -15
NOPAT Margin
11.55% 11.96% 15.18% 13.56% 13.28% 12.81% 8.92% 3.19% 4.44% -83.01% -1.74%
Net Nonoperating Expense Percent (NNEP)
-0.52% 0.91% 1.59% 1.68% 1.29% 0.25% 0.33% 36.40% 7.32% 47.75% -1.12%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - -25.05% -0.52%
Cost of Revenue to Revenue
52.36% 52.85% 53.19% 53.66% 53.06% 54.09% 53.90% 50.64% 49.81% 52.90% 53.07%
SG&A Expenses to Revenue
9.09% 9.55% 9.62% 9.85% 10.60% 10.93% 15.70% 24.46% 21.63% 24.39% 28.16%
R&D to Revenue
3.08% 2.90% 2.73% 3.09% 3.53% 3.47% 3.23% 3.17% 2.43% 2.36% 2.11%
Operating Expenses to Revenue
30.09% 29.02% 29.17% 29.90% 30.79% 30.07% 34.98% 44.80% 43.85% 165.69% 49.41%
Earnings before Interest and Taxes (EBIT)
55 66 71 68 66 74 59 31 53 -1,065 49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
67 80 88 86 85 95 83 124 177 -936 173
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.58 5.12 6.97 4.60 5.20 5.88 3.22 1.21 0.91 0.61 0.93
Price to Tangible Book Value (P/TBV)
7.20 8.10 8.76 5.66 6.87 8.01 4.48 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.77 6.73 9.81 7.09 9.01 10.54 5.41 4.60 3.08 1.42 2.24
Price to Earnings (P/E)
50.67 55.09 61.85 48.81 63.36 81.13 59.06 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.97% 1.82% 1.62% 2.05% 1.58% 1.23% 1.69% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
5.89 6.92 10.58 7.21 8.98 9.93 4.88 1.17 0.92 0.73 0.97
Enterprise Value to Revenue (EV/Rev)
5.43 6.33 9.28 6.45 8.19 9.73 4.69 5.38 3.86 2.28 2.94
Enterprise Value to EBITDA (EV/EBITDA)
25.98 28.24 41.83 31.13 40.43 48.14 29.76 35.67 20.10 0.00 14.84
Enterprise Value to EBIT (EV/EBIT)
31.74 34.56 51.84 39.18 51.64 61.89 41.94 143.78 67.63 0.00 52.69
Enterprise Value to NOPAT (EV/NOPAT)
47.01 52.97 61.17 47.53 61.66 75.98 52.56 168.37 86.84 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
49.38 37.65 53.44 41.81 39.88 56.22 36.33 107.77 101.12 34.97 30.78
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 204.86 94.35 75.64 77.35 0.00 0.00 0.00 0.00 6.20 18.59
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.28 0.43 0.38
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.28 0.42 0.38
Financial Leverage
-0.29 -0.29 -0.34 -0.40 -0.45 -0.46 -0.44 0.07 0.22 0.28 0.31
Leverage Ratio
1.12 1.12 1.11 1.10 1.10 1.10 1.11 1.38 1.45 1.53 1.63
Compound Leverage Factor
1.13 1.13 1.15 1.17 1.19 1.12 1.13 -0.99 -0.39 1.63 -0.30
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.03% 22.03% 30.15% 27.50%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.65% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.03% 22.03% 29.50% 27.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.01% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.01% 99.97% 100.00% 100.00% 100.00% 100.00% 100.00% 77.97% 77.97% 69.85% 72.50%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.14 5.01 -0.96 4.60
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.16 4.04 -0.82 3.53
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.14 5.01 -0.93 4.60
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 33.72 21.63 -1.20 -52.49
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 24.37 17.47 -1.03 -40.22
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 33.72 21.63 -1.18 -52.49
Altman Z-Score
26.77 28.01 43.01 32.94 33.78 39.43 18.44 2.09 1.74 -0.28 1.18
Noncontrolling Interest Sharing Ratio
-0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
8.68 8.14 9.71 11.75 11.08 11.03 8.05 4.03 3.82 3.32 3.82
Quick Ratio
6.14 5.89 7.49 9.15 8.83 8.82 6.18 2.74 2.23 1.62 2.10
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-20 11 39 35 44 -18 -0.00 -3,253 -46 329 138
Operating Cash Flow to CapEx
248.43% 413.46% 330.04% 435.45% 357.05% 303.57% 278.51% 63.19% 31.68% 58.52% 162.50%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 -228.11 -0.01 -58.12 -0.63 4.59 2.39
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 1,039.60 944.97 0.73 0.48 0.81 1.44
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 697.14 605.68 -0.43 -1.04 -0.58 0.56
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.76 0.73 0.69 0.63 0.56 0.55 0.55 0.30 0.20 0.22 0.26
Accounts Receivable Turnover
5.07 5.26 5.39 5.12 5.00 5.31 5.51 6.50 5.67 5.48 5.80
Inventory Turnover
2.90 2.75 2.84 2.74 2.45 2.59 2.55 3.25 2.85 2.49 2.76
Fixed Asset Turnover
6.48 6.15 5.90 5.60 5.45 5.23 5.00 5.32 3.88 2.90 2.60
Accounts Payable Turnover
11.41 11.82 11.44 11.17 9.93 10.23 9.71 7.49 5.76 5.82 5.82
Days Sales Outstanding (DSO)
72.06 69.39 67.72 71.23 73.00 68.76 66.30 56.12 64.42 66.58 62.94
Days Inventory Outstanding (DIO)
125.82 132.54 128.60 133.01 148.91 140.98 143.24 112.23 128.09 146.58 132.40
Days Payable Outstanding (DPO)
32.00 30.88 31.90 32.69 36.78 35.69 37.58 48.76 63.33 62.72 62.70
Cash Conversion Cycle (CCC)
165.89 171.05 164.43 171.56 185.13 174.06 171.95 119.59 129.19 150.43 132.64
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
296 328 349 370 382 459 506 3,785 3,873 2,804 2,651
Invested Capital Turnover
1.20 1.15 1.17 1.15 1.11 1.11 1.09 0.38 0.24 0.27 0.32
Increase / (Decrease) in Invested Capital
58 32 21 21 11 78 47 3,279 87 -1,071 -153
Enterprise Value (EV)
1,745 2,269 3,695 2,669 3,425 4,559 2,472 4,422 3,566 2,037 2,561
Market Capitalization
1,853 2,413 3,905 2,937 3,768 4,940 2,853 3,782 2,848 1,272 1,953
Book Value per Share
$10.77 $12.37 $10.86 $12.24 $13.71 $15.70 $8.23 $14.50 $14.52 $9.54 $9.61
Tangible Book Value per Share
$6.85 $7.82 $8.64 $9.95 $10.36 $11.52 $5.91 ($2.81) ($2.32) ($1.86) ($1.25)
Total Capital
404 472 560 638 725 840 887 4,020 4,033 2,965 2,887
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 885 888 894 794
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 885 888 875 794
Net Debt
-108 -144 -211 -268 -344 -381 -381 640 717 765 608
Capital Expenditures (CapEx)
14 15 21 15 24 27 24 65 111 100 51
Debt-free, Cash-free Net Working Capital (DFCFNWC)
112 113 126 144 145 157 168 195 264 293 261
Debt-free Net Working Capital (DFNWC)
220 257 337 411 489 538 549 440 435 422 446
Net Working Capital (NWC)
220 257 337 411 489 538 549 440 435 403 446
Net Nonoperating Expense (NNE)
0.57 -1.14 -2.81 -4.01 -3.93 -0.89 -1.27 49 50 349 -7.22
Net Nonoperating Obligations (NNO)
-108 -144 -211 -268 -344 -381 -381 651 728 732 558
Total Depreciation and Amortization (D&A)
12 15 17 18 18 21 24 93 125 129 124
Debt-free, Cash-free Net Working Capital to Revenue
34.81% 31.63% 31.74% 34.71% 34.73% 33.46% 31.85% 23.70% 28.56% 32.77% 29.97%
Debt-free Net Working Capital to Revenue
68.36% 71.72% 84.71% 99.30% 116.92% 114.81% 104.13% 53.55% 47.06% 47.19% 51.29%
Net Working Capital to Revenue
68.36% 71.72% 84.71% 99.30% 116.92% 114.81% 104.13% 53.55% 47.06% 45.04% 51.29%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.37 $0.43 $0.62 $0.58 $0.57 $0.57 $0.45 ($0.12) ($0.04) ($5.03) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding
100.20M 101.90M 103.51M 104.56M 105.10M 106.50M 107.68M 188.88M 216.48M 216.89M 217.50M
Adjusted Diluted Earnings per Share
$0.36 $0.43 $0.61 $0.58 $0.57 $0.57 $0.45 ($0.12) ($0.04) ($5.03) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding
100.20M 101.90M 103.51M 104.56M 105.72M 107.12M 108.02M 188.88M 216.48M 216.89M 217.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
100.20M 101.90M 103.51M 104.56M 105.93M 107.48M 107.84M 216.31M 216.69M 217.21M 218.06M
Normalized Net Operating Profit after Tax (NOPAT)
37 43 60 56 56 60 47 26 41 -1.17 -15
Normalized NOPAT Margin
11.55% 11.96% 15.18% 13.56% 13.28% 12.81% 8.92% 3.19% 4.44% -0.13% -1.74%
Pre Tax Income Margin
17.28% 18.61% 18.46% 17.62% 17.29% 16.07% 11.42% -2.68% -1.55% -126.65% -1.03%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 944.28 818.61 0.55 0.72 -14.86 0.84
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 769.14 653.22 0.47 0.56 -10.37 -0.26
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 601.82 479.32 -0.61 -0.80 -16.25 -0.05
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 426.68 313.93 -0.69 -0.96 -11.76 -1.15
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 5.21% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Neogen

This table displays calculated financial ratios and metrics derived from Neogen's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
DEI Shares Outstanding
- - - - - 217,038,267.00 - - 217,673,041.00 217,673,041.00 218,306,034.00
DEI Adjusted Shares Outstanding
- - - - - 217,038,267.00 - - 217,673,041.00 217,673,041.00 218,306,034.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -2.82 - - -0.08 -0.05 -0.05
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.84% -2.07% 0.00% 0.71% -3.42% -9.37% -3.58% -2.84% -4.43% -0.07% 6.50%
EBITDA Growth
-3.57% -19.00% -31.82% -1,174.14% -9.23% -1,037.98% 172.17% 105.44% -38.73% 106.45% -67.00%
EBIT Growth
-25.47% -54.78% -89.02% -3,796.71% -32.62% -2,342.31% 2,847.44% 98.67% -187.67% 100.29% -101.86%
NOPAT Growth
-23.34% -46.50% -90.86% -3,262.70% -54.96% -1,888.04% -944.81% 98.82% -161.11% 100.52% 90.56%
Net Income Growth
-124.69% -197.18% 0.00% -12,985.23% -441.89% -7,122.36% 388.19% 96.51% -55.96% 98.15% -132.78%
EPS Growth
-125.00% -166.67% 0.00% -10,400.00% -400.00% -5,740.00% 383.33% 96.67% -60.00% 97.87% -129.41%
Operating Cash Flow Growth
-76.96% -70.60% -177.86% 0.00% 164.10% -38.77% 160.58% -51.70% 16.66% 84.15% 19.44%
Free Cash Flow Firm Growth
99.10% 97.60% 216.47% 263.78% 1,590.29% 1,077.14% -171.35% 1,025.21% 67.49% -75.90% 105.22%
Invested Capital Growth
1.00% 2.31% 0.00% -10.09% -11.43% -27.65% 0.00% -21.47% -21.86% -5.45% -5.29%
Revenue Q/Q Growth
-0.36% 3.49% -8.37% 0.00% -4.44% 2.03% 0.00% 7.41% -6.00% 6.69% -1.12%
EBITDA Q/Q Growth
-3.25% 9.66% -27.97% 0.00% 108.18% -1,639.02% 0.00% -73.80% -1.30% 62.09% -20.06%
EBIT Q/Q Growth
-12.65% 2.53% -81.91% 0.00% 101.59% -8,520.66% 0.00% -110.29% -4.78% 127.75% -161.94%
NOPAT Q/Q Growth
-16.88% 8.46% -82.69% 0.00% 101.18% -11,418.02% 0.00% 71.80% 38.63% 196.00% -156.82%
Net Income Q/Q Growth
42.01% -167.80% -132.85% 0.00% 97.60% -5,516.60% 0.00% -143.82% -6.76% 33.45% -5.18%
EPS Q/Q Growth
50.00% -100.00% -200.00% 0.00% 97.62% -5,540.00% 0.00% -141.18% -14.29% 25.00% 16.67%
Operating Cash Flow Q/Q Growth
-292.22% 188.55% -166.98% 0.00% 0.00% -15.73% -34.39% 79.16% 16.76% 33.02% -57.28%
Free Cash Flow Firm Q/Q Growth
24.79% -161.41% 4,945.94% 0.00% 584.37% 44.33% 0.00% 126.29% 1.87% -79.23% -6.08%
Invested Capital Q/Q Growth
1.34% 0.10% -100.00% 0.00% -0.17% -18.18% 0.00% -2.90% -0.67% -1.00% -0.82%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
51.08% 47.92% 48.36% 49.01% 49.90% 41.18% 45.40% 47.48% 46.88% 47.86% 47.35%
EBITDA Margin
18.08% 19.16% 15.06% -198.57% 16.99% -256.17% 42.51% 10.37% 10.89% 16.54% 13.38%
Operating Margin
5.25% 5.51% 1.04% -197.82% 2.45% -271.06% -7.69% -2.39% -1.56% 1.41% -0.81%
EBIT Margin
4.74% 4.70% 0.93% -198.57% 3.31% -272.62% 28.36% -2.72% -3.03% 0.79% -0.49%
Profit (Net Income) Margin
-0.88% -2.29% -5.81% -197.30% -4.96% -271.52% 17.37% -7.09% -8.05% -5.02% -5.34%
Tax Burden Percent
34.73% 84.62% 80.78% 95.74% 112.65% 96.99% 82.95% 78.20% 83.74% 93.17% 79.87%
Interest Burden Percent
-53.65% -57.52% -775.41% 103.78% -133.05% 102.69% 73.84% 333.40% 317.19% -683.78% 1,354.55%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.05% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.89% 0.93% 0.00% 0.00% 0.00% -50.84% -4.08% -0.48% -0.31% 0.31% -0.19%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.57% -1.18% 0.00% 0.00% 0.00% -76.04% 11.04% -2.28% -2.50% -1.78% -1.96%
Return on Net Nonoperating Assets (RNNOA)
-0.13% -0.26% 0.00% 0.00% 0.00% -21.33% 3.43% -0.65% -0.70% -0.55% -0.56%
Return on Equity (ROE)
0.76% 0.67% 0.00% 0.00% 0.00% -72.17% -0.65% -1.13% -1.02% -0.24% -0.74%
Cash Return on Invested Capital (CROIC)
0.26% -1.21% 0.00% 0.00% 0.00% 9.84% -254.44% 9.72% 9.96% 5.05% 5.25%
Operating Return on Assets (OROA)
0.97% 0.95% 0.00% 0.00% 0.00% -61.04% 7.45% -0.65% -0.71% 0.20% -0.13%
Return on Assets (ROA)
-0.18% -0.46% 0.00% 0.00% 0.00% -60.79% 4.56% -1.68% -1.90% -1.29% -1.41%
Return on Common Equity (ROCE)
0.76% 0.67% 0.00% 0.00% 0.00% -72.17% -0.65% -1.13% -1.02% -0.24% -0.74%
Return on Equity Simple (ROE_SIMPLE)
0.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
8.42 9.13 1.58 -320 3.79 -428 -13 -3.76 -2.31 2.22 -1.26
NOPAT Margin
3.68% 3.85% 0.73% -138.48% 1.72% -189.74% -6.38% -1.68% -1.09% 0.98% -0.57%
Net Nonoperating Expense Percent (NNEP)
1.46% 2.11% 0.00% 18.98% 1.98% 25.20% -15.12% 1.80% 2.19% 2.10% 1.77%
Return On Investment Capital (ROIC_SIMPLE)
0.21% - - -8.99% 0.11% -14.43% -0.46% -0.13% -0.08% 0.08% -0.04%
Cost of Revenue to Revenue
48.92% 52.08% 51.64% 50.99% 50.10% 58.82% 54.60% 52.52% 53.13% 52.14% 52.65%
SG&A Expenses to Revenue
22.76% 21.52% 23.82% 24.98% 25.24% 23.49% 29.11% 29.02% 28.55% 26.05% 26.62%
R&D to Revenue
2.12% 2.17% 2.40% 2.21% 2.02% 2.79% 2.45% 2.03% 1.80% 2.18% 2.92%
Operating Expenses to Revenue
45.83% 42.42% 47.32% 246.83% 47.45% 312.23% 53.09% 49.87% 48.44% 46.46% 48.16%
Earnings before Interest and Taxes (EBIT)
11 11 2.01 -459 7.31 -615 59 -6.11 -6.40 1.78 -1.10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
41 45 33 -459 38 -578 89 23 23 37 30
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.18 0.91 0.00 1.15 0.82 0.61 0.59 0.62 1.16 0.93 1.21
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.01 3.08 4.04 0.00 0.00 1.42 1.41 1.48 2.81 2.24 2.85
Price to Earnings (P/E)
2,376.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.15 0.92 0.00 1.11 0.86 0.73 0.69 0.72 1.15 0.97 1.19
Enterprise Value to Revenue (EV/Rev)
4.78 3.86 0.00 0.00 0.00 2.28 2.15 2.21 3.53 2.94 3.53
Enterprise Value to EBITDA (EV/EBITDA)
23.62 20.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.84 27.88
Enterprise Value to EBIT (EV/EBIT)
67.08 67.63 0.00 0.00 0.00 0.00 0.00 0.00 0.00 52.69 0.00
Enterprise Value to NOPAT (EV/NOPAT)
91.89 86.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
44.64 101.12 0.00 202.59 43.00 35.00 21.87 29.41 44.30 30.78 36.61
Enterprise Value to Free Cash Flow (EV/FCFF)
444.31 0.00 0.00 0.00 0.00 6.20 0.00 6.54 10.12 18.59 22.02
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.28 0.28 0.00 0.33 0.33 0.43 0.37 0.38 0.38 0.38 0.37
Long-Term Debt to Equity
0.28 0.28 0.00 0.33 0.33 0.42 0.37 0.38 0.38 0.38 0.37
Financial Leverage
0.23 0.22 0.00 0.25 0.26 0.28 0.31 0.28 0.28 0.31 0.29
Leverage Ratio
1.45 1.45 0.00 1.49 1.48 1.53 1.59 1.55 1.55 1.63 1.59
Compound Leverage Factor
-0.78 -0.83 0.00 1.54 -1.97 1.57 1.18 5.18 4.93 -11.15 21.52
Debt to Total Capital
22.01% 22.03% 0.00% 25.06% 25.08% 30.15% 27.22% 27.37% 27.40% 27.50% 27.06%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.07% 0.00% 0.65% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
22.01% 22.03% 0.00% 24.99% 25.08% 29.50% 27.22% 27.37% 27.40% 27.50% 27.06%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
77.99% 77.97% 0.00% 74.94% 74.92% 69.85% 72.78% 72.63% 72.60% 72.50% 72.94%
Debt to EBITDA
4.72 5.01 0.00 0.00 0.00 -0.96 -0.90 -1.85 -1.79 4.60 6.91
Net Debt to EBITDA
3.82 4.04 0.00 0.00 0.00 -0.82 -0.74 -1.51 -1.43 3.53 5.38
Long-Term Debt to EBITDA
4.72 5.01 0.00 0.00 0.00 -0.93 -0.90 -1.85 -1.79 4.60 6.91
Debt to NOPAT
18.37 21.63 0.00 0.00 0.00 -1.20 -1.05 -1.81 -1.78 -52.49 -151.51
Net Debt to NOPAT
14.88 17.47 0.00 0.00 0.00 -1.03 -0.87 -1.47 -1.42 -40.22 -117.85
Long-Term Debt to NOPAT
18.37 21.63 0.00 0.00 0.00 -1.18 -1.05 -1.81 -1.78 -52.49 -151.51
Altman Z-Score
2.05 1.71 0.00 0.00 0.00 0.15 0.84 0.81 1.35 1.13 1.43
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.82 3.82 0.00 3.77 3.91 3.32 3.58 3.91 3.92 3.82 3.90
Quick Ratio
2.17 2.23 0.00 2.01 2.04 1.62 1.90 1.89 1.97 2.10 2.06
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-30 -78 3,909 65 446 644 -2,789 733 747 155 146
Operating Cash Flow to CapEx
-94.01% 110.49% -52.71% 0.00% 59.68% 103.14% 45.22% 166.63% 196.87% 755.00% 157.32%
Free Cash Flow to Firm to Interest Expense
-1.64 -4.20 209.99 3.59 25.14 43.65 -169.64 49.38 53.73 12.50 10.56
Operating Cash Flow to Interest Expense
-1.65 1.44 -0.96 0.00 1.09 1.11 0.66 1.31 1.63 2.43 0.93
Operating Cash Flow Less CapEx to Interest Expense
-3.41 0.14 -2.79 0.00 -0.74 0.03 -0.80 0.52 0.80 2.11 0.34
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.20 0.20 0.00 0.00 0.00 0.22 0.26 0.24 0.24 0.26 0.26
Accounts Receivable Turnover
5.81 5.67 0.00 0.00 0.00 5.48 6.41 5.95 5.86 5.80 6.44
Inventory Turnover
2.79 2.85 0.00 0.00 0.00 2.49 2.46 2.63 2.60 2.76 2.74
Fixed Asset Turnover
4.25 3.88 0.00 0.00 0.00 2.90 2.56 2.74 2.64 2.60 2.62
Accounts Payable Turnover
6.07 5.76 0.00 0.00 0.00 5.82 6.21 6.67 6.47 5.82 6.03
Days Sales Outstanding (DSO)
62.84 64.42 0.00 0.00 0.00 66.58 56.98 61.38 62.30 62.94 56.70
Days Inventory Outstanding (DIO)
130.68 128.09 0.00 0.00 0.00 146.55 148.48 138.55 140.46 132.40 133.25
Days Payable Outstanding (DPO)
60.18 63.33 0.00 0.00 0.00 62.72 58.80 54.73 56.41 62.70 60.52
Cash Conversion Cycle (CCC)
133.34 129.19 0.00 0.00 0.00 150.41 146.66 145.20 146.35 132.64 129.44
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,869 3,873 0.00 3,432 3,427 2,804 2,776 2,695 2,678 2,651 2,629
Invested Capital Turnover
0.24 0.24 0.00 0.00 0.00 0.27 0.64 0.29 0.29 0.32 0.33
Increase / (Decrease) in Invested Capital
38 87 -3,907 -385 -442 -1,071 2,776 -737 -749 -153 -147
Enterprise Value (EV)
4,441 3,566 0.00 3,825 2,943 2,037 1,903 1,947 3,076 2,561 3,123
Market Capitalization
3,722 2,848 3,738 3,073 2,180 1,272 1,249 1,299 2,443 1,953 2,521
Book Value per Share
$14.53 $14.52 $0.00 $12.32 $12.26 $9.54 $9.75 $9.68 $9.67 $9.61 $9.57
Tangible Book Value per Share
($2.45) ($2.32) $0.00 ($2.15) ($2.08) ($1.86) ($1.55) ($1.38) ($1.32) ($1.25) ($1.18)
Total Capital
4,034 4,033 0.00 3,562 3,551 2,965 2,911 2,897 2,896 2,887 2,861
Total Debt
888 888 0.00 892 891 894 793 793 793 794 774
Total Long-Term Debt
888 888 0.00 890 891 875 793 793 793 794 774
Net Debt
719 717 0.00 752 763 765 654 648 633 608 602
Capital Expenditures (CapEx)
32 24 34 0.00 32 16 24 12 12 4.00 8.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)
276 264 0.00 282 283 293 239 282 280 261 261
Debt-free Net Working Capital (DFNWC)
445 435 0.00 422 411 422 378 428 439 446 433
Net Working Capital (NWC)
445 435 0.00 419 411 403 378 428 439 446 433
Net Nonoperating Expense (NNE)
10 15 14 136 15 184 -50 12 15 14 11
Net Nonoperating Obligations (NNO)
723 728 0.00 763 766 732 657 591 575 558 543
Total Depreciation and Amortization (D&A)
31 34 31 0.00 30 37 30 29 29 36 31
Debt-free, Cash-free Net Working Capital to Revenue
29.72% 28.56% 0.00% 0.00% 0.00% 32.77% 26.95% 32.06% 32.11% 29.97% 29.52%
Debt-free Net Working Capital to Revenue
47.85% 47.06% 0.00% 0.00% 0.00% 47.19% 42.60% 48.56% 50.48% 51.29% 48.98%
Net Working Capital to Revenue
47.85% 47.06% 0.00% 0.00% 0.00% 45.03% 42.60% 48.56% 50.48% 51.29% 48.98%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.01) ($0.02) $0.00 ($2.10) ($0.05) ($2.82) $0.17 ($0.07) ($0.08) ($0.06) ($0.05)
Adjusted Weighted Average Basic Shares Outstanding
216.60M 216.48M 0.00 216.81M 217.03M 216.90M 217.22M 217.41M 217.67M 217.50M 218.10M
Adjusted Diluted Earnings per Share
($0.01) ($0.02) $0.00 ($2.10) ($0.05) ($2.82) $0.17 ($0.07) ($0.08) ($0.06) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding
216.60M 216.48M 0.00 216.81M 217.03M 216.90M 217.33M 217.41M 217.67M 217.50M 218.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
216.61M 216.69M 0.00 216.94M 217.04M 217.21M 217.30M 217.53M 217.67M 218.06M 218.31M
Normalized Net Operating Profit after Tax (NOPAT)
8.42 9.13 1.58 2.73 3.79 -428 -13 -3.76 -2.31 2.22 -1.26
Normalized NOPAT Margin
3.68% 3.85% 0.73% 1.18% 1.72% -189.74% -6.38% -1.68% -1.09% 0.98% -0.57%
Pre Tax Income Margin
-2.54% -2.70% -7.19% -206.08% -4.40% -279.95% 20.94% -9.06% -9.61% -5.39% -6.69%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.59 0.60 0.11 -25.31 0.41 -41.69 3.61 -0.41 -0.46 0.14 -0.08
NOPAT to Interest Expense
0.46 0.49 0.08 -17.65 0.21 -29.02 -0.81 -0.25 -0.17 0.18 -0.09
EBIT Less CapEx to Interest Expense
-1.16 -0.70 -1.72 0.00 -1.42 -42.77 2.15 -1.20 -1.29 -0.18 -0.67
NOPAT Less CapEx to Interest Expense
-1.30 -0.81 -1.74 0.00 -1.62 -30.10 -2.27 -1.04 -1.00 -0.14 -0.69
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Neogen’s financial results show gradual operational improvement, but profitability remains under pressure. Revenue in Q1 fiscal 2027 increased to $222.8 million from $209.2 million in Q1 fiscal 2026, although it remained below the $225.3 million reported in Q4 fiscal 2026. Gross profit was $105.5 million, producing a gross margin of approximately 47.4%, up from about 45.4% a year earlier. This improvement indicates better cost control or product mix, despite relatively flat quarterly revenue.

Operating performance also improved year over year. The company’s operating loss narrowed to $1.8 million in Q1 fiscal 2027 from $16.1 million in Q1 fiscal 2026. However, higher interest costs and the company’s sizable debt balance continued to weigh on results. Neogen reported a net loss of $11.9 million, or $0.05 per diluted share, compared with a $12.6 million loss in Q1 fiscal 2025 and a $15.9 million loss in Q2 fiscal 2026.

Cash generation remains positive but modest relative to the company’s debt obligations. Operating cash flow was $12.9 million in Q1 fiscal 2027, down sharply from $30.2 million in Q4 fiscal 2026 but above the $10.8 million generated in Q1 fiscal 2026. After capital expenditures of $8.2 million, debt repayment of $20 million and other financing outflows, cash declined by $13.5 million during the quarter. The balance sheet remains liquid, although goodwill and intangible assets account for roughly 71% of total assets, increasing the importance of future operating performance and impairment testing.

  • Revenue recovered year over year: Q1 fiscal 2027 revenue rose approximately 6.5% from Q1 fiscal 2026 to $222.8 million.
  • Gross margin improved: Gross margin increased to approximately 47.4% from 45.4% a year earlier, suggesting improved cost absorption or product mix.
  • Operating losses narrowed: The operating loss improved to $1.8 million from $16.1 million year over year, moving Neogen closer to breakeven.
  • Operating cash flow remained positive: Neogen generated $12.9 million from operations in Q1 fiscal 2027, marking a continued source of internal liquidity despite reported net losses.
  • Strong short-term liquidity: Cash and equivalents totaled $172 million, while current assets of $582.5 million compared favorably with current liabilities of $149.5 million.
  • Debt reduction continued: The company repaid $20 million of debt during the quarter, but long-term debt still stood at $774.2 million and cash interest paid was $21.5 million.
  • Capital spending remains meaningful: Capital expenditures were $8.2 million in Q1 fiscal 2027, supporting the business but limiting free cash flow while earnings remain negative.
  • Results are affected by historical restatements and acquisition accounting: Earlier periods include significant impairment charges and unusual non-cash adjustments, making direct four-year comparisons less clean.
  • Neogen remains unprofitable: The company posted a $11.9 million net loss in Q1 fiscal 2027, extending a pattern of quarterly losses following the large impairment-related losses recorded in fiscal 2025.
  • Interest expense continues to pressure earnings: Q1 fiscal 2027 interest expense was $13.8 million, offsetting the company’s near-breakeven operating result and contributing to the pretax loss.
11/16/26 06:55 PM ETAI Generated. May Contain Errors.

Neogen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Neogen's fiscal year ends in May. Their fiscal year 2026 ended on May 31, 2026.

Neogen's net income appears to be on a downward trend, with a most recent value of -$7.90 million in 2026, compared with $36.54 million in 2016. The previous period was -$1.09 billion in 2025. Find out what analysts predict for Neogen in the coming months.

Neogen's total operating income in 2026 was -$21.60 million, based on the following breakdown:
  • Total Gross Profit: $408.50 million
  • Total Operating Expenses: $430.10 million

Over the last 10 years, Neogen's total revenue changed from $321.28 million in 2016 to $870.40 million in 2026, a change of 170.9%.

In the past 14 quarters, Neogen's cash and equivalents has ranged from $67.13 million in Q3 2023 to $205.77 million in Q2 2024, and is currently $172 million as of their latest financial filing in Q1 2027.

Neogen had total debt of $793.70 million at the end of 2026, a 11.2% decrease from 2025, and none in 2016.

Over the last 10 years, Neogen's book value per share changed from 10.77 in 2016 to 9.61 in 2026, a change of -10.7%.



Financial statements for NASDAQ:NEOG last updated on 10/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners